Gillespie Robinson & Grimm Inc. cut its stake in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 1.3% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 21,833 shares of the medical instruments supplier’s stock after selling 282 shares during the period. Gillespie Robinson & Grimm Inc. owned about 0.09% of Mettler-Toledo International worth $13,296,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Morgan Stanley lifted its position in Mettler-Toledo International by 47.9% during the second quarter. Morgan Stanley now owns 74,688 shares of the medical instruments supplier’s stock valued at $43,217,000 after purchasing an additional 24,177 shares in the last quarter. Bessemer Group Inc. raised its holdings in Mettler-Toledo International by 24.7% during the second quarter. Bessemer Group Inc. now owns 3,055 shares of the medical instruments supplier’s stock valued at $1,767,000 after acquiring an additional 605 shares during the period. Ontario Teachers Pension Plan Board raised its holdings in Mettler-Toledo International by 65.4% during the second quarter. Ontario Teachers Pension Plan Board now owns 52,446 shares of the medical instruments supplier’s stock valued at $30,347,000 after acquiring an additional 20,732 shares during the period. Schwab Charles Investment Management Inc. raised its holdings in Mettler-Toledo International by 3.8% during the second quarter. Schwab Charles Investment Management Inc. now owns 95,465 shares of the medical instruments supplier’s stock valued at $55,239,000 after acquiring an additional 3,525 shares during the period. Finally, Epoch Investment Partners Inc. bought a new stake in Mettler-Toledo International during the second quarter valued at about $3,309,000. Institutional investors own 92.93% of the company’s stock.
In other news, insider La Guerroniere Marc De sold 4,609 shares of Mettler-Toledo International stock in a transaction dated Thursday, August 30th. The stock was sold at an average price of $580.37, for a total value of $2,674,925.33. Following the sale, the insider now directly owns 4,609 shares of the company’s stock, valued at $2,674,925.33. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP William P. Donnelly sold 2,000 shares of Mettler-Toledo International stock in a transaction dated Monday, August 6th. The stock was sold at an average price of $588.60, for a total value of $1,177,200.00. Following the completion of the sale, the executive vice president now directly owns 2,000 shares in the company, valued at $1,177,200. The disclosure for this sale can be found here. Insiders sold 18,358 shares of company stock worth $10,744,204 over the last ninety days. Insiders own 4.80% of the company’s stock.
Mettler-Toledo International (NYSE:MTD) last issued its earnings results on Thursday, July 26th. The medical instruments supplier reported $4.65 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $4.58 by $0.07. Mettler-Toledo International had a return on equity of 90.80% and a net margin of 13.52%. The firm had revenue of $722.00 million for the quarter, compared to analysts’ expectations of $715.69 million. During the same period in the previous year, the firm posted $3.92 earnings per share. The business’s revenue was up 10.4% compared to the same quarter last year. Sell-side analysts anticipate that Mettler-Toledo International Inc. will post 20.15 earnings per share for the current fiscal year.
A number of equities research analysts have commented on MTD shares. Zacks Investment Research cut Mettler-Toledo International from a “buy” rating to a “hold” rating in a report on Tuesday. Morgan Stanley decreased their price target on Mettler-Toledo International from $568.00 to $540.00 and set an “equal weight” rating on the stock in a report on Friday, July 13th. UBS Group started coverage on Mettler-Toledo International in a report on Tuesday, October 9th. They set a “neutral” rating and a $625.00 price target on the stock. Finally, JPMorgan Chase & Co. raised their price target on Mettler-Toledo International from $550.00 to $600.00 and gave the company a “neutral” rating in a report on Friday, July 27th. Eleven research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. Mettler-Toledo International has an average rating of “Hold” and a consensus target price of $621.82.
Mettler-Toledo International Profile
Mettler-Toledo International Inc manufactures and supplies precision instruments and services worldwide. The company operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. It offers weighing instruments for laboratory, industrial, packaging, logistics, and food retailing applications; analytical instruments for use in life science; various related analytical instruments and provides automated chemistry solutions used in drug and chemical compound discovery and development; and end-of-line product inspection systems used in production and packaging for food processing and packaging, pharmaceutical, packaged consumer goods, and other industries.
Further Reading: How to calculate the intrinsic value of a stock
Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International Inc. (NYSE:MTD).
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.